Purchase Order 75N95025P00423

Award Date 9/24/25
Potential Completion Date 9/23/26
Potential Value $175K
Ultimate Awardee
Not listed
PSC Category
6810 - Chemicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $99,955 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to Enamine US Inc. The contract is for the provision of a virtual chemical compound library to support COVID-19 research. Enamine US Inc. is a for-profit company that specializes in developing and providing chemical compounds and related research services to the life sciences industry, including past work...
This is a $21,296 firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), part of the U.S. Department of Health and Human Services (HHS), to Enamine US Inc. for a set of compounds/molecules. The contract has no set-aside designation. Enamine US Inc. is a for-profit organization that provides chemical compounds and research services to support pharmaceutical, biotechnology, and other life science companies and research organizations....
This firm fixed price purchase order awards Enamine LTD $230,323.60 to provide the National Center for Advancing Translational Sciences two general GPCR libraries totaling 27,000 compounds at $5.20 per compound. The libraries will support the National Institutes of Health's National Institute on Drug Abuse in identifying and developing novel small molecule leads against human disease targets through screening of thousands of compounds. One library will contain a minimum of 25,000 general GPCR...
This federal contract award, valued at $21,400.00, was issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) to Enamine US Inc., a for-profit organization. The contract is for ADME (absorption, distribution, metabolism, and excretion) evaluation assays of compounds generated by Enamine. This is a firm fixed-price purchase order with an ultimate completion date of August 27, 2025. Enamine has previously provided various chemical products and research services to the...
This is a firm fixed price purchase order contract awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a component of the U.S. Department of Health and Human Services (HHS), to Enamine LTD, a limited liability company based in Cincinnati, Ohio. The contract is for LC-MS/MS analysis services to support the NIAAA's biomedical research programs. The total ceiling value of the contract is $14,964.80 and the ultimate completion date is November 22, 2023. The contract does not...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $103,000.00 firm-fixed-price purchase order to ChemDiv, Inc. to provide a compound library of 8,000 specific and unique small molecule compounds. The compounds are being procured for the National Center for Advancing Translational Sciences (NCATS) to support their Genesis screening library. The contract does not have a set-aside designation, and the place of performance is San...
This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $27,400.00, is for lab testing services and was set aside for a small business, Enamine US Inc. Based in New Jersey, Enamine US Inc. is a for-profit organization that specializes in chemical research and pharmaceutical services, and has a history of delivering...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $29,820 firm fixed price purchase order to Medchemexpress LLC to deliver forty-four bioactive compounds for replenishment and expansion of the Mechanism Interrogation PlatE 6.0 screening library. The compounds will support the Center's high-capacity robotic platform used to screen drug combinations and further its chemogenomic screening capabilities. Delivery...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $19,800 firm fixed price purchase order to Karebay Biochem Inc., a for-profit small business, to synthesize 200 grams of compound NCGC00413972. This order supports NIH's biomedical research programs, particularly in the areas of drug discovery and infectious disease. Karebay Biochem has received multiple prior purchase orders from NIH entities to...
This federal contract award was issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the U.S. Department of Health and Human Services, to Enamine US Inc., a for-profit small business. The $20,176 firm fixed-price purchase order is for a pharmacokinetic study in C57BL6 mice, which is a key part of the agency's research program. The contract has a period of performance through August 4, 2026 and was set aside for small businesses. Enamine US Inc. is...

The National Institutes of Health (NIH) has awarded a $175,000.00 firm-fixed-price purchase order to Enamine US Inc., a for-profit chemical research and pharmaceutical services company, to expand the Covalent Screening Library of Small Molecules. This contract, which is not set aside for any specific business type, aims to provide the National Center for Advancing Translational Sciences (NCATS) Experimental Therapeutics Branch with 1,000 compounds (500 from Sulfamoyl Fluorides set and 500 from Cyanamides set) to enhance their high-throughput screening capabilities and target previously undruggable proteins. The contract has a completion date of September 23, 2026. Enamine US Inc. has demonstrated a track record of delivering specialized scientific services to various NIH institutes, including the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute of Child Health and Human Development (NICHD).

Generated 9/26/25, 9:59 AM